샘플 요청 목록

 카트 문의
시장보고서
상품코드
2070349

체외진단 기기 시장 규모와 예측(2021-2034년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 범위 : 기기별, 기술별, 용도별, 사용법별, 검사 장소별, 최종사용자별, 지역별

In-Vitro Diagnostic Instruments Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Instruments, Technology, Application, Usability, Site Of Testing, End User, and Geography
발행일: | 리서치사: 구분자 The Insight Partners | 페이지 정보: 영문 601 Pages | 배송안내 : 즉시배송

    
    
    



가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다.
US $ 4,450 금액 안내 화살표 ￦ 6,928,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,450 금액 안내 화살표 ￦ 10,042,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,450 금액 안내 화살표 ￦ 13,155,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

체외진단 기기 시장 규모는 2025년 263억 달러에서 2034년까지 491억 5,000만 달러로 확대될 것으로 예상되고, 2026년부터 2034년까지 CAGR 7.2%를 기록할 것으로 전망됩니다.

만성 질환의 유병률 증가와 감염병을 감시하는 공중보건 검사 프로그램의 시행은 체외진단 기기 시장의 확대에 기여하는 주목할 만한 요인입니다. 또한, 지속적인 기술 발전과 새로운 진단 제품의 개발로 인해 가까운 시일 내에 시장에 새로운 동향이 나타날 것으로 예상됩니다.

전 세계 체외진단(IVD) 수요를 견인하는 주요 요인은 당뇨병, 심혈관질환, 암, 호흡기질환 등 만성 비감염성 질환(NCD)의 유병률이 급속히 증가하고 있다는 점이며, 이러한 질환의 선별 검사, 진단 및 관리에는 빈번한 임상 검사가 필요합니다. 세계보건기구(WHO)에 따르면, 2021년에는 비전염성 질환(NCDs)이 최소 4,300만 명의 사망 원인이 되었으며, 이는 팬데믹을 제외한 전체 사망자의 약 75%를 차지합니다. 전 세계적으로 볼 때, 심혈관질환과 암이 주요 원인으로 꼽히며, 이러한 지속적인 부담은 2025년까지 특히 저·중소득 국가에서 계속될 전망이며, 이에 따라 진단 검사 인프라 및 시약에 대한 수요가 증가하고 있습니다.

미국에서는 CDC(미국 질병통제예방센터)의 “2026년 전국 당뇨병 통계 보고서”에 따르면, 2023년 기준으로 진단받았거나 미진단 상태인 당뇨병을 앓고 있는 미국인은 약 4,010만 명(인구의 12%)에 달하며, 1억 1,500만 명 이상의 성인이 당뇨병 전 단계에 있는 것으로 나타났으며, 만성 질환에 대한 검사 수요가 높아짐에 따라 혈당 검사 및 관련 바이오마커 진단 시장이 성장하고 있는 것으로 밝혀졌습니다. 국제적으로, WHO 보고서에 따르면 전 세계적으로 약 8억 3,000만 명이 당뇨병을 앓고 있으며, 2025년에도 이러한 전 세계적 부담이 지속될 것으로 드러나, 진단 및 모니터링에 대한 장기적인 필요성이 강조되고 있습니다.

북미, 유럽, 아시아태평양 등 여러 지역에 걸쳐 만성 질환이 이처럼 광범위하게 확산됨에 따라, 의료 시스템과 공중보건 프로그램은 확장성이 뛰어난 체외진단(IVD) 솔루션, 특히 면역분석법, 임상화학 검사, 분자진단 플랫폼 및 현장 진단(POCT)에 대한 투자를 확대할 수밖에 없는 상황입니다.

용도별·채널별 분석

기기별로 보면 체외진단 기기 시장은 임상화학 분석기, 면역측정기, 혈액학·응고 분석기, 분자진단 플랫폼, 미생물학·감염증 진단 장치, 혈액가스·전해질 분석 장치, 유세포 분석기, 소변 검사 장치, 혈액은행·수혈 의학용 장치, 검체 전처리·보조 장치, 그리고 특수·연구용 기기로 분류됩니다. 2025년에는 면역측정 기기 부문이 체외 진단 기기 시장에서 가장 큰 점유율을 차지했습니다. 면역분석 장치는 체외 진단(IVD) 기기 시장의 중요한 부문으로서, 고감도 바이오마커 검출에 대한 수요 증가, 질병 감시 활동의 확대, 그리고 규제 당국의 지속적인 지원을 받은 혁신에 힘입어 꾸준히 성장하고 있습니다. 세계보건기구(WHO)에 따르면, 임상 판단의 약 70%는 진단 검사에 기반을 두고 있으며(2023년), 면역측정법은 감염병, 암, 호르몬 장애의 검출에 있어 핵심적인 역할을 하고 있습니다. 만성 질환과 감염병으로 인한 부담은 계속해서 증가하고 있습니다. 예를 들어, 미국 질병통제예방센터(CDC)는 2024년에 성인 10명 중 6명이 적어도 하나의 만성 질환을 앓고 있다고 보고했으며, 이로 인해 면역측정 플랫폼에서 수행되는 바이오마커 기반 검사의 필요성이 높아지고 있습니다. 규제 당국의 움직임 또한 이러한 성장을 뒷받침하고 있습니다. 2023년, 미국 식품의약국(FDA)은 자동 분석 기기를 위해 설계된 HIV 및 매독 항체 검사를 포함한 여러 면역분석법에 기반한 진단 기기를 승인했습니다. 2024년에는 추가적인 면역 검사법(예 : 거대세포바이러스 및 트레포네마 검사 등)이 고처리량 플랫폼용으로 승인되면서, 실험실 내 도입 확대가 촉진되었습니다. 2025년까지 자동 분석기와 통합된 화학발광식 HIV 항원·항체 검사 등 첨단 면역분석 시스템과 검사법의 승인이 잇따르고 있어, 지속적인 혁신과 도입이 진행되고 있음이 부각되고 있습니다. 또한, 2024년 FDA가 제정한 실험실 개발 검사(LDT)에 대한 감독을 강화하는 규정에 따라 품질이 향상되고, 표준화된 자동 면역분석기의 도입이 촉진되고 있습니다. 검사 건수의 증가, 전기화학발광 플랫폼 등의 기술적 진보, 그리고 질병의 조기 발견을 위한 전 세계적인 보건 이니셔티브가 맞물리면서, 이러한 요인들이 면역분석 장비가 IVD 기기 시장에서 성장 분야로 부상한 이유를 설명해 줍니다.

목차

제1장 주요 요약

제2장 체외진단 기기 시장 전망

제3장 경쟁 구도

제4장 체외진단 기기 시장 : 주요 업계 역학

제5장 체외진단 기기 시장 : 세계 시장 분석

제6장 체외진단 기기 시장 매출 분석 : 기기 종류별

제7장 체외진단 기기 시장 매출 분석 : 기술별

제8장 체외진단 기기 시장 매출 분석 : 용도별

제9장 체외진단 기기 시장 매출 분석 : 사용법별

제10장 체외진단 기기 시장 매출 분석 : 검사 장소별

제11장 체외진단 기기 시장 매출 분석 : 검체별

제12장 체외진단 기기 시장 매출 분석 : 최종사용자별

제13장 체외진단 기기 시장 : 지역별 분석

제14장 체외진단 기기 시장 : 업계 상황

제15장 체외진단 기기 시장 : 주요 기업 개요

제16장 기타 분석 대상 기업 리스트

제17장 부록

KSM

The In-Vitro Diagnostic Instruments market size is expected to grow from US$ 26.30 billion in 2025 to US$ 49.15 billion by 2034; it is projected to register a CAGR of 7.2% during 2026-2034.

The rising incidence of chronic diseases, public health testing programs that monitor infectious diseases are noteworthy factors contributing to the expansion of the In-Vitro Diagnostic Instruments market. Additionally, the ongoing technological advancements, and new diagnostic product developments are projected to bring new market drifts in the near future.

A primary driver of global IVD Diagnostic Instruments demand is the accelerating prevalence of chronic non-communicable diseases (NCDs) such as diabetes, cardiovascular disease, cancer, and respiratory conditions, which require frequent laboratory testing for screening, diagnosis, and management. According to the World Health Organization (WHO), NCDs accounted for at least 43 million deaths in 2021, representing roughly 75% of all non-pandemic-related deaths, with cardiovascular disease and cancer leading contributors globally; this enduring burden continued till 2025, especially in low- and middle-income countries, intensifying the need for diagnostic testing infrastructure and reagents.

In the US, the CDC's 2026 National Diabetes Statistics Report showed an estimated 40.1 million Americans (12%) living with diagnosed or undiagnosed diabetes in 2023, with over 115 million adults having prediabetes, demonstrating high chronic disease testing demand driving glucose testing and related biomarker diagnostics. Internationally, approximately 830 million individuals worldwide had diabetes, as reported by WHO, underscoring a global burden that persisted in 2025 and highlighting the long-term need for diagnostic monitoring.

Such widespread chronic disease prevalence across regions such as North America, Europe, and Asia Pacific forces healthcare systems and public health programs to invest in scalable IVD solutions, particularly immunoassays, clinical chemistry, molecular platforms, and point-of-care tests.

Application Channel -Based Insights

By instrument, the In-Vitro Diagnostic Instruments market is segmented into clinical chemistry analyzers, immunoassay instruments, hematology and coagulation analyzers, molecular diagnostics platforms, microbiology and infectious disease instruments, blood gas and electrolyte analyzers, flow cytometers, urinalysis instruments, blood bank and transfusion medicine instruments, specimen prep and ancillary instruments, and specialty and research-grade instruments. In 2025, the immunoassay instruments segment held the largest In-Vitro Diagnostic Instruments market share. Immunoassay instruments, as a critical segment within the in-vitro diagnostic (IVD) instruments market, are growing steadily due to rising demand for sensitive biomarker detection, expanding disease surveillance, and continuous regulatory-supported innovation. According to the World Health Organization, diagnostic testing underpins around 70% of clinical decision-making (2023), and immunoassays are central to detecting infectious diseases, cancers, and hormonal disorders. The burden of chronic and infectious diseases continues to rise; for example, the Centers for Disease Control and Prevention reported in 2024 that 6 in 10 adults live with at least one chronic disease, increasing the need for biomarker-based testing performed on immunoassay platforms. Regulatory activity further demonstrates growth: in 2023, the U.S. Food and Drug Administration approved multiple immunoassay-based diagnostic devices, including HIV and syphilis antibody tests designed for automated analyzer systems . In 2024, additional immunoassay assays (e.g., cytomegalovirus and treponemal tests) were cleared for high-throughput platforms, supporting expanded laboratory adoption . By 2025, continued approvals of advanced immunoassay systems and assays-such as chemiluminescent HIV antigen/antibody tests integrated with automated analyzers-highlight ongoing innovation and deployment . Furthermore, the FDA's 2024 rule strengthening oversight of laboratory-developed tests is improving quality and encouraging adoption of standardized, automated immunoassay instruments. Combined with increasing testing volumes, technological advancements like electrochemiluminescence platforms, and global health initiatives for early disease detection, these factors explain why immunoassay instruments are a growing segment within the IVD instruments market.

The World Health Organization, Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), Health Sciences Authority, the Italian National Institute of Statistics (ISTAT), South Korea Food and Drug Administration (KFDA), are among the primary and secondary sources referred to while preparing the In-Vitro Diagnostic Instruments market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. In-Vitro Diagnostic Instruments Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
  • 2.10 Patent Analysis
  • 2.11 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. In-Vitro Diagnostic Instruments Market - Key Industry Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Future Trends
  • 4.5 Impact of Drivers and Restraints

5. In-Vitro Diagnostic Instruments Market - Global Market Analysis

  • 5.1 In-Vitro Diagnostic Instruments Market Revenue (US$ Million), 2021-2034
  • 5.2 In-Vitro Diagnostic Instruments Market Forecast and Analysis

6. In-Vitro Diagnostic Instruments Market Revenue Analysis - Instrument Type

  • 6.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by Instrument Type
    • 6.1.1 Clinical Chemistry Analyzers
      • 6.1.1.1 Overview
      • 6.1.1.2 Clinical Chemistry Analyzers: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Immunoassay Instruments
      • 6.1.2.1 Overview
      • 6.1.2.2 Immunoassay Instruments: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Hematology and Coagulation Analyzers
      • 6.1.3.1 Overview
      • 6.1.3.2 Hematology and Coagulation Analyzers: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.4 Molecular Diagnostics Platforms
      • 6.1.4.1 Overview
      • 6.1.4.2 Molecular Diagnostics Platforms: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.5 Microbiology and Infectious Disease Instruments
      • 6.1.5.1 Overview
      • 6.1.5.2 Microbiology and Infectious Disease Instruments: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.6 Blood Gas and Electrolyte Analyzers
      • 6.1.6.1 Overview
      • 6.1.6.2 Blood Gas and Electrolyte Analyzers: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.7 Flow Cytometers
      • 6.1.7.1 Overview
      • 6.1.7.2 Flow Cytometers: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.8 Urinalysis Instruments
      • 6.1.8.1 Overview
      • 6.1.8.2 Urinalysis Instruments: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.9 Blood Bank and Transfusion Medicine Instruments
      • 6.1.9.1 Overview
      • 6.1.9.2 Blood Bank and Transfusion Medicine Instruments: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.10 Specimen Prep and Ancillary Instruments
      • 6.1.10.1 Overview
      • 6.1.10.2 Specimen Prep and Ancillary Instruments: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.11 Specialty and Research-Grade Instruments
      • 6.1.11.1 Overview
      • 6.1.11.2 Specialty and Research-Grade Instruments: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

7. In-Vitro Diagnostic Instruments Market Revenue Analysis - Technology

  • 7.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by Technology
    • 7.1.1 Immunoassay or Immunochemistry
      • 7.1.1.1 Overview
      • 7.1.1.2 Immunoassay or Immunochemistry: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Immunochromatography
      • 7.1.2.1 Overview
      • 7.1.2.2 Immunochromatography: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Cellular analysis
      • 7.1.3.1 Overview
      • 7.1.3.2 Cellular analysis: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.4 Proteomic or metabolomic
      • 7.1.4.1 Overview
      • 7.1.4.2 Proteomic or metabolomic: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.5 Sensor technology
      • 7.1.5.1 Overview
      • 7.1.5.2 Sensor technology: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.6 Miniaturized systems
      • 7.1.6.1 Overview
      • 7.1.6.2 Miniaturized systems: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.7 Multiplex technology
      • 7.1.7.1 Overview
      • 7.1.7.2 Multiplex technology: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.8 Optical detection
      • 7.1.8.1 Overview
      • 7.1.8.2 Optical detection: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.9 Electrochemical analysis
      • 7.1.9.1 Overview
      • 7.1.9.2 Electrochemical analysis: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.10 Separation technology
      • 7.1.10.1 Overview
      • 7.1.10.2 Separation technology: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.11 Molecular Diagnosis
      • 7.1.11.1 Overview
      • 7.1.11.2 Molecular Diagnosis: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.12 Analytical chemistry
      • 7.1.12.1 Overview
      • 7.1.12.2 Analytical chemistry: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.13 Molecular amplification
      • 7.1.13.1 Overview
      • 7.1.13.2 Molecular amplification: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.14 Molecular genomics
      • 7.1.14.1 Overview
      • 7.1.14.2 Molecular genomics: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.15 High-throughput molecular
      • 7.1.15.1 Overview
      • 7.1.15.2 High-throughput molecular: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.16 Genetic Analysis
      • 7.1.16.1 Overview
      • 7.1.16.2 Genetic Analysis: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

8. In-Vitro Diagnostic Instruments Market Revenue Analysis - Application

  • 8.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by Application
    • 8.1.1 Infectious Diseases
      • 8.1.1.1 Overview
      • 8.1.1.2 Infectious Diseases: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Oncology
      • 8.1.2.1 Overview
      • 8.1.2.2 Oncology: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Cardiology
      • 8.1.3.1 Overview
      • 8.1.3.2 Cardiology: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Nephrology
      • 8.1.4.1 Overview
      • 8.1.4.2 Nephrology: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.5 Diabetes
      • 8.1.5.1 Overview
      • 8.1.5.2 Diabetes: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.6 Genetic Diseases
      • 8.1.6.1 Overview
      • 8.1.6.2 Genetic Diseases: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.7 Blood Grouping and Testing
      • 8.1.7.1 Overview
      • 8.1.7.2 Blood Grouping and Testing: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.8 Allergy Diagnostics
      • 8.1.8.1 Overview
      • 8.1.8.2 Allergy Diagnostics: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.9 Gastrointestinal Diseases
      • 8.1.9.1 Overview
      • 8.1.9.2 Gastrointestinal Diseases: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.10 Immune System Disorders
      • 8.1.10.1 Overview
      • 8.1.10.2 Immune System Disorders: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.11 Others
      • 8.1.11.1 Overview
      • 8.1.11.2 Others: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

9. In-Vitro Diagnostic Instruments Market Revenue Analysis - Usability

  • 9.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by Usability
    • 9.1.1 Disposable Devices
      • 9.1.1.1 Overview
      • 9.1.1.2 Disposable Devices: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.2 Reusable Equipment
      • 9.1.2.1 Overview
      • 9.1.2.2 Reusable Equipment: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

10. In-Vitro Diagnostic Instruments Market Revenue Analysis - Site Of Testing

  • 10.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by Site Of Testing
    • 10.1.1 Laboratory Tests
      • 10.1.1.1 Overview
      • 10.1.1.2 Laboratory Tests: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.2 Point of Care Tests
      • 10.1.2.1 Overview
      • 10.1.2.2 Point of Care Tests: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

11. In-Vitro Diagnostic Instruments Market Revenue Analysis - Specimen

  • 11.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by Specimen
    • 11.1.1 Blood Serum and Plasma
      • 11.1.1.1 Overview
      • 11.1.1.2 Blood Serum and Plasma: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.2 Saliva Specimens
      • 11.1.2.1 Overview
      • 11.1.2.2 Saliva Specimens: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.3 Urine Specimens
      • 11.1.3.1 Overview
      • 11.1.3.2 Urine Specimens: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.4 Others
      • 11.1.4.1 Overview
      • 11.1.4.2 Others: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

12. In-Vitro Diagnostic Instruments Market Revenue Analysis - End User

  • 12.1 In-Vitro Diagnostic Instruments Market Forecasts and Analysis by End User
    • 12.1.1 Hospitals
      • 12.1.1.1 Overview
      • 12.1.1.2 Hospitals: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.2 Clinical Laboratories
      • 12.1.2.1 Overview
      • 12.1.2.2 Clinical Laboratories: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.3 Home Care
      • 12.1.3.1 Overview
      • 12.1.3.2 Home Care: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.4 Others
      • 12.1.4.1 Overview
      • 12.1.4.2 Others: In-Vitro Diagnostic Instruments Market - Revenue, 2021-2034 (US$ Million)

13. In-Vitro Diagnostic Instruments Market - Geographical Analysis

  • 13.1 North America
    • 13.1.1 North America In-Vitro Diagnostic Instruments Market Overview
    • 13.1.2 North America: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.1.3 North America: In-Vitro Diagnostic Instruments Market - By Segmentation
      • 13.1.3.1 Instrument Type
      • 13.1.3.2 Clinical Chemistry Analyzers
      • 13.1.3.3 Immunoassay Instruments
      • 13.1.3.4 Urinalysis Instruments
      • 13.1.3.5 Technology
      • 13.1.3.6 Application
      • 13.1.3.7 Usability
      • 13.1.3.8 Site Of Testing
      • 13.1.3.9 Specimen
      • 13.1.3.10 End User
    • 13.1.4 North America: In-Vitro Diagnostic Instruments Market Breakdown by Countries
      • 13.1.4.1 United States Market
        • 13.1.4.1.1 United States: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.1.2 United States: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.1.4.1.2.1 Instrument Type
          • 13.1.4.1.2.2 Clinical Chemistry Analyzers
          • 13.1.4.1.2.3 Immunoassay Instruments
          • 13.1.4.1.2.4 Urinalysis Instruments
          • 13.1.4.1.2.5 Technology
          • 13.1.4.1.2.6 Application
          • 13.1.4.1.2.7 Usability
          • 13.1.4.1.2.8 Site Of Testing
          • 13.1.4.1.2.9 Specimen
          • 13.1.4.1.2.10 End User
      • 13.1.4.2 Canada Market
        • 13.1.4.2.1 Canada: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.2.2 Canada: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.1.4.2.2.1 Instrument Type
          • 13.1.4.2.2.2 Clinical Chemistry Analyzers
          • 13.1.4.2.2.3 Immunoassay Instruments
          • 13.1.4.2.2.4 Urinalysis Instruments
          • 13.1.4.2.2.5 Technology
          • 13.1.4.2.2.6 Application
          • 13.1.4.2.2.7 Usability
          • 13.1.4.2.2.8 Site Of Testing
          • 13.1.4.2.2.9 Specimen
          • 13.1.4.2.2.10 End User
      • 13.1.4.3 Mexico Market
        • 13.1.4.3.1 Mexico: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.3.2 Mexico: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.1.4.3.2.1 Instrument Type
          • 13.1.4.3.2.2 Clinical Chemistry Analyzers
          • 13.1.4.3.2.3 Immunoassay Instruments
          • 13.1.4.3.2.4 Urinalysis Instruments
          • 13.1.4.3.2.5 Technology
          • 13.1.4.3.2.6 Application
          • 13.1.4.3.2.7 Usability
          • 13.1.4.3.2.8 Site Of Testing
          • 13.1.4.3.2.9 Specimen
          • 13.1.4.3.2.10 End User
  • 13.2 Europe
    • 13.2.1 Europe In-Vitro Diagnostic Instruments Market Overview
    • 13.2.2 Europe: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.2.3 Europe: In-Vitro Diagnostic Instruments Market - By Segmentation
      • 13.2.3.1 Instrument Type
      • 13.2.3.2 Clinical Chemistry Analyzers
      • 13.2.3.3 Immunoassay Instruments
      • 13.2.3.4 Urinalysis Instruments
      • 13.2.3.5 Technology
      • 13.2.3.6 Application
      • 13.2.3.7 Usability
      • 13.2.3.8 Site Of Testing
      • 13.2.3.9 Specimen
      • 13.2.3.10 End User
    • 13.2.4 Europe: In-Vitro Diagnostic Instruments Market Breakdown by Countries
      • 13.2.4.1 Germany Market
        • 13.2.4.1.1 Germany: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.1.2 Germany: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.2.4.1.2.1 Instrument Type
          • 13.2.4.1.2.2 Clinical Chemistry Analyzers
          • 13.2.4.1.2.3 Immunoassay Instruments
          • 13.2.4.1.2.4 Urinalysis Instruments
          • 13.2.4.1.2.5 Technology
          • 13.2.4.1.2.6 Application
          • 13.2.4.1.2.7 Usability
          • 13.2.4.1.2.8 Site Of Testing
          • 13.2.4.1.2.9 Specimen
          • 13.2.4.1.2.10 End User
      • 13.2.4.2 France Market
        • 13.2.4.2.1 France: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.2.2 France: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.2.4.2.2.1 Instrument Type
          • 13.2.4.2.2.2 Clinical Chemistry Analyzers
          • 13.2.4.2.2.3 Immunoassay Instruments
          • 13.2.4.2.2.4 Urinalysis Instruments
          • 13.2.4.2.2.5 Technology
          • 13.2.4.2.2.6 Application
          • 13.2.4.2.2.7 Usability
          • 13.2.4.2.2.8 Site Of Testing
          • 13.2.4.2.2.9 Specimen
          • 13.2.4.2.2.10 End User
      • 13.2.4.3 Italy Market
        • 13.2.4.3.1 Italy: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.3.2 Italy: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.2.4.3.2.1 Instrument Type
          • 13.2.4.3.2.2 Clinical Chemistry Analyzers
          • 13.2.4.3.2.3 Immunoassay Instruments
          • 13.2.4.3.2.4 Urinalysis Instruments
          • 13.2.4.3.2.5 Technology
          • 13.2.4.3.2.6 Application
          • 13.2.4.3.2.7 Usability
          • 13.2.4.3.2.8 Site Of Testing
          • 13.2.4.3.2.9 Specimen
          • 13.2.4.3.2.10 End User
      • 13.2.4.4 United Kingdom Market
        • 13.2.4.4.1 United Kingdom: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.4.2 United Kingdom: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.2.4.4.2.1 Instrument Type
          • 13.2.4.4.2.2 Clinical Chemistry Analyzers
          • 13.2.4.4.2.3 Immunoassay Instruments
          • 13.2.4.4.2.4 Urinalysis Instruments
          • 13.2.4.4.2.5 Technology
          • 13.2.4.4.2.6 Application
          • 13.2.4.4.2.7 Usability
          • 13.2.4.4.2.8 Site Of Testing
          • 13.2.4.4.2.9 Specimen
          • 13.2.4.4.2.10 End User
      • 13.2.4.5 Spain Market
        • 13.2.4.5.1 Spain: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.5.2 Spain: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.2.4.5.2.1 Instrument Type
          • 13.2.4.5.2.2 Clinical Chemistry Analyzers
          • 13.2.4.5.2.3 Immunoassay Instruments
          • 13.2.4.5.2.4 Urinalysis Instruments
          • 13.2.4.5.2.5 Technology
          • 13.2.4.5.2.6 Application
          • 13.2.4.5.2.7 Usability
          • 13.2.4.5.2.8 Site Of Testing
          • 13.2.4.5.2.9 Specimen
          • 13.2.4.5.2.10 End User
      • 13.2.4.6 Rest of Europe Market
        • 13.2.4.6.1 Rest of Europe: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.6.2 Rest of Europe: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.2.4.6.2.1 Instrument Type
          • 13.2.4.6.2.2 Clinical Chemistry Analyzers
          • 13.2.4.6.2.3 Immunoassay Instruments
          • 13.2.4.6.2.4 Urinalysis Instruments
          • 13.2.4.6.2.5 Technology
          • 13.2.4.6.2.6 Application
          • 13.2.4.6.2.7 Usability
          • 13.2.4.6.2.8 Site Of Testing
          • 13.2.4.6.2.9 Specimen
          • 13.2.4.6.2.10 End User
  • 13.3 Asia Pacific
    • 13.3.1 Asia Pacific In-Vitro Diagnostic Instruments Market Overview
    • 13.3.2 Asia Pacific: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.3.3 Asia Pacific: In-Vitro Diagnostic Instruments Market - By Segmentation
      • 13.3.3.1 Instrument Type
      • 13.3.3.2 Clinical Chemistry Analyzers
      • 13.3.3.3 Immunoassay Instruments
      • 13.3.3.4 Urinalysis Instruments
      • 13.3.3.5 Technology
      • 13.3.3.6 Application
      • 13.3.3.7 Usability
      • 13.3.3.8 Site Of Testing
      • 13.3.3.9 Specimen
      • 13.3.3.10 End User
    • 13.3.4 Asia Pacific: In-Vitro Diagnostic Instruments Market Breakdown by Countries
      • 13.3.4.1 China Market
        • 13.3.4.1.1 China: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.1.2 China: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.3.4.1.2.1 Instrument Type
          • 13.3.4.1.2.2 Clinical Chemistry Analyzers
          • 13.3.4.1.2.3 Immunoassay Instruments
          • 13.3.4.1.2.4 Urinalysis Instruments
          • 13.3.4.1.2.5 Technology
          • 13.3.4.1.2.6 Application
          • 13.3.4.1.2.7 Usability
          • 13.3.4.1.2.8 Site Of Testing
          • 13.3.4.1.2.9 Specimen
          • 13.3.4.1.2.10 End User
      • 13.3.4.2 Japan Market
        • 13.3.4.2.1 Japan: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.2.2 Japan: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.3.4.2.2.1 Instrument Type
          • 13.3.4.2.2.2 Clinical Chemistry Analyzers
          • 13.3.4.2.2.3 Immunoassay Instruments
          • 13.3.4.2.2.4 Urinalysis Instruments
          • 13.3.4.2.2.5 Technology
          • 13.3.4.2.2.6 Application
          • 13.3.4.2.2.7 Usability
          • 13.3.4.2.2.8 Site Of Testing
          • 13.3.4.2.2.9 Specimen
          • 13.3.4.2.2.10 End User
      • 13.3.4.3 India Market
        • 13.3.4.3.1 India: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.3.2 India: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.3.4.3.2.1 Instrument Type
          • 13.3.4.3.2.2 Clinical Chemistry Analyzers
          • 13.3.4.3.2.3 Immunoassay Instruments
          • 13.3.4.3.2.4 Urinalysis Instruments
          • 13.3.4.3.2.5 Technology
          • 13.3.4.3.2.6 Application
          • 13.3.4.3.2.7 Usability
          • 13.3.4.3.2.8 Site Of Testing
          • 13.3.4.3.2.9 Specimen
          • 13.3.4.3.2.10 End User
      • 13.3.4.4 Australia Market
        • 13.3.4.4.1 Australia: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.4.2 Australia: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.3.4.4.2.1 Instrument Type
          • 13.3.4.4.2.2 Clinical Chemistry Analyzers
          • 13.3.4.4.2.3 Immunoassay Instruments
          • 13.3.4.4.2.4 Urinalysis Instruments
          • 13.3.4.4.2.5 Technology
          • 13.3.4.4.2.6 Application
          • 13.3.4.4.2.7 Usability
          • 13.3.4.4.2.8 Site Of Testing
          • 13.3.4.4.2.9 Specimen
          • 13.3.4.4.2.10 End User
      • 13.3.4.5 South Korea Market
        • 13.3.4.5.1 South Korea: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.5.2 South Korea: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.3.4.5.2.1 Instrument Type
          • 13.3.4.5.2.2 Clinical Chemistry Analyzers
          • 13.3.4.5.2.3 Immunoassay Instruments
          • 13.3.4.5.2.4 Urinalysis Instruments
          • 13.3.4.5.2.5 Technology
          • 13.3.4.5.2.6 Application
          • 13.3.4.5.2.7 Usability
          • 13.3.4.5.2.8 Site Of Testing
          • 13.3.4.5.2.9 Specimen
          • 13.3.4.5.2.10 End User
      • 13.3.4.6 Rest of Asia Pacific Market
        • 13.3.4.6.1 Rest of Asia Pacific: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.6.2 Rest of Asia Pacific: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.3.4.6.2.1 Instrument Type
          • 13.3.4.6.2.2 Clinical Chemistry Analyzers
          • 13.3.4.6.2.3 Immunoassay Instruments
          • 13.3.4.6.2.4 Urinalysis Instruments
          • 13.3.4.6.2.5 Technology
          • 13.3.4.6.2.6 Application
          • 13.3.4.6.2.7 Usability
          • 13.3.4.6.2.8 Site Of Testing
          • 13.3.4.6.2.9 Specimen
          • 13.3.4.6.2.10 End User
  • 13.4 Middle East and Africa
    • 13.4.1 Middle East and Africa In-Vitro Diagnostic Instruments Market Overview
    • 13.4.2 Middle East and Africa: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.4.3 Middle East and Africa: In-Vitro Diagnostic Instruments Market - By Segmentation
      • 13.4.3.1 Instrument Type
      • 13.4.3.2 Clinical Chemistry Analyzers
      • 13.4.3.3 Immunoassay Instruments
      • 13.4.3.4 Urinalysis Instruments
      • 13.4.3.5 Technology
      • 13.4.3.6 Application
      • 13.4.3.7 Usability
      • 13.4.3.8 Site Of Testing
      • 13.4.3.9 Specimen
      • 13.4.3.10 End User
    • 13.4.4 Middle East and Africa: In-Vitro Diagnostic Instruments Market Breakdown by Countries
      • 13.4.4.1 South Africa Market
        • 13.4.4.1.1 South Africa: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.1.2 South Africa: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.4.4.1.2.1 Instrument Type
          • 13.4.4.1.2.2 Clinical Chemistry Analyzers
          • 13.4.4.1.2.3 Immunoassay Instruments
          • 13.4.4.1.2.4 Urinalysis Instruments
          • 13.4.4.1.2.5 Technology
          • 13.4.4.1.2.6 Application
          • 13.4.4.1.2.7 Usability
          • 13.4.4.1.2.8 Site Of Testing
          • 13.4.4.1.2.9 Specimen
          • 13.4.4.1.2.10 End User
      • 13.4.4.2 Saudi Arabia Market
        • 13.4.4.2.1 Saudi Arabia: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.2.2 Saudi Arabia: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.4.4.2.2.1 Instrument Type
          • 13.4.4.2.2.2 Clinical Chemistry Analyzers
          • 13.4.4.2.2.3 Immunoassay Instruments
          • 13.4.4.2.2.4 Urinalysis Instruments
          • 13.4.4.2.2.5 Technology
          • 13.4.4.2.2.6 Application
          • 13.4.4.2.2.7 Usability
          • 13.4.4.2.2.8 Site Of Testing
          • 13.4.4.2.2.9 Specimen
          • 13.4.4.2.2.10 End User
      • 13.4.4.3 United Arab Emirates Market
        • 13.4.4.3.1 United Arab Emirates: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.3.2 United Arab Emirates: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.4.4.3.2.1 Instrument Type
          • 13.4.4.3.2.2 Clinical Chemistry Analyzers
          • 13.4.4.3.2.3 Immunoassay Instruments
          • 13.4.4.3.2.4 Urinalysis Instruments
          • 13.4.4.3.2.5 Technology
          • 13.4.4.3.2.6 Application
          • 13.4.4.3.2.7 Usability
          • 13.4.4.3.2.8 Site Of Testing
          • 13.4.4.3.2.9 Specimen
          • 13.4.4.3.2.10 End User
      • 13.4.4.4 Rest of Middle East and Africa Market
        • 13.4.4.4.1 Rest of Middle East and Africa: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.4.2 Rest of Middle East and Africa: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.4.4.4.2.1 Instrument Type
          • 13.4.4.4.2.2 Clinical Chemistry Analyzers
          • 13.4.4.4.2.3 Immunoassay Instruments
          • 13.4.4.4.2.4 Urinalysis Instruments
          • 13.4.4.4.2.5 Technology
          • 13.4.4.4.2.6 Application
          • 13.4.4.4.2.7 Usability
          • 13.4.4.4.2.8 Site Of Testing
          • 13.4.4.4.2.9 Specimen
          • 13.4.4.4.2.10 End User
  • 13.5 South and Central America
    • 13.5.1 South and Central America In-Vitro Diagnostic Instruments Market Overview
    • 13.5.2 South and Central America: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.5.3 South and Central America: In-Vitro Diagnostic Instruments Market - By Segmentation
      • 13.5.3.1 Instrument Type
      • 13.5.3.2 Clinical Chemistry Analyzers
      • 13.5.3.3 Immunoassay Instruments
      • 13.5.3.4 Urinalysis Instruments
      • 13.5.3.5 Technology
      • 13.5.3.6 Application
      • 13.5.3.7 Usability
      • 13.5.3.8 Site Of Testing
      • 13.5.3.9 Specimen
      • 13.5.3.10 End User
    • 13.5.4 South and Central America: In-Vitro Diagnostic Instruments Market Breakdown by Countries
      • 13.5.4.1 Brazil Market
        • 13.5.4.1.1 Brazil: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.1.2 Brazil: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.5.4.1.2.1 Instrument Type
          • 13.5.4.1.2.2 Clinical Chemistry Analyzers
          • 13.5.4.1.2.3 Immunoassay Instruments
          • 13.5.4.1.2.4 Urinalysis Instruments
          • 13.5.4.1.2.5 Technology
          • 13.5.4.1.2.6 Application
          • 13.5.4.1.2.7 Usability
          • 13.5.4.1.2.8 Site Of Testing
          • 13.5.4.1.2.9 Specimen
          • 13.5.4.1.2.10 End User
      • 13.5.4.2 Argentina Market
        • 13.5.4.2.1 Argentina: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.2.2 Argentina: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.5.4.2.2.1 Instrument Type
          • 13.5.4.2.2.2 Clinical Chemistry Analyzers
          • 13.5.4.2.2.3 Immunoassay Instruments
          • 13.5.4.2.2.4 Urinalysis Instruments
          • 13.5.4.2.2.5 Technology
          • 13.5.4.2.2.6 Application
          • 13.5.4.2.2.7 Usability
          • 13.5.4.2.2.8 Site Of Testing
          • 13.5.4.2.2.9 Specimen
          • 13.5.4.2.2.10 End User
      • 13.5.4.3 Rest of South and Central America Market
        • 13.5.4.3.1 Rest of South and Central America: In-Vitro Diagnostic Instruments Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.3.2 Rest of South and Central America: In-Vitro Diagnostic Instruments Market - By Segmentation
          • 13.5.4.3.2.1 Instrument Type
          • 13.5.4.3.2.2 Clinical Chemistry Analyzers
          • 13.5.4.3.2.3 Immunoassay Instruments
          • 13.5.4.3.2.4 Urinalysis Instruments
          • 13.5.4.3.2.5 Technology
          • 13.5.4.3.2.6 Application
          • 13.5.4.3.2.7 Usability
          • 13.5.4.3.2.8 Site Of Testing
          • 13.5.4.3.2.9 Specimen
          • 13.5.4.3.2.10 End User

14. In-Vitro Diagnostic Instruments Market Industry Landscape

15. In-Vitro Diagnostic Instruments Market - Key Company Profiles

  • 15.1 Bio-Rad Laboratories Inc
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 Abbott
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 F. Hoffmann-La Roche Ltd
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Danaher Corp
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Siemens AG
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Thermo Fisher Scientific Inc.
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 bioMerieux SA
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Sysmex Corp
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Becton Dickinson and Co
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. List of Additional Companies Analyzed

  • 16.1 List of Additional Companies Analyzed

17. Appendix

  • 17.1 Glossary
  • 17.2 Research Methodology and Approach
    • 17.2.1 Secondary Research
    • 17.2.2 Primary Research
    • 17.2.3 Market Estimation Approach
      • 17.2.3.1 Supply Side Analysis
      • 17.2.3.2 Demand Side Analysis
    • 17.2.4 Research Assumptions and Limitations
    • 17.2.5 Currency Conversion
  • 17.3 About The Insight Partners
  • 17.4 Market Intelligence Cloud
×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
문의하기